Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Semaglutide in Patients With Psoriasis and Obesity

NCT06937060 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06937060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06937060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Semaglutide in Patients With Psoriasis and Obesity
Lead sponsor
The University of Hong Kong
Phase
Phase 3
Overall status
Recruiting
Start date
March 20, 2025
Completion date
January 31, 2027
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity and overweight, psoriasis (pso)